Related Experiment Video
Updated: May 11, 2026
Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
Suppression of Human Liver Cancer Cell Migration and Invasion via the GABAA Receptor
Zhi-Ao Chen1, Mei-Yan Bao, Yong-Fen Xu
1State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200032, China.
Objective:
To investigate the roles of the γ-aminobutyric acid (GABA) in the metastasis of hepatocellular carcinoma (HCC) and to explore the potential of a novel therapeutic approach for the treatment of HCC.
Methods:
The expression levels of GABA receptor subunit genes in various HCC cell lines and patients' tissues were detected by quantitative real-time polymerase chain reaction and Western blot analysis. Transwell cell migration and invasion assays were carried out for functional analysis. The effects of GABA on liver cancer cell cytoskeletal were determined by immunofluorescence staining. And the effects of GABA on HCC metastasis in nude mice were evaluated using an in vivo orthotopic model of liver cancer.
Results:
The mRNA level of GABA receptor subunits varied between the primary hepatocellular carcinoma tissue and the adjacent non-tumor liver tissue. GABA inhibited human liver cancer cell migration and invasion via the ionotropic GABAA receptor as a result of the induction of liver cancer cell cytoskeletal reorganization. Pretreatment with GABA also significantly reduced intrahepatic liver metastasis and primary tumor formation in vivo.
Conclusions:
These findings introduce a potential and novel therapeutic approach for the treatment of cancer patients based on the modulation of the GABAergic system.
Insights
Gamma-aminobutyric acid (GABA) inhibits hepatocellular carcinoma (HCC) metastasis by reorganizing liver cancer cell cytoskeleton. Modulating the GABAergic system offers a novel therapeutic strategy for HCC treatment.
Area of Science:
- Oncology
- Neuroscience
- Molecular Biology
Background:
- Hepatocellular carcinoma (HCC) is a major global health concern with limited effective treatments.
- Metastasis is a key driver of HCC mortality.
- The role of neurotransmitters like gamma-aminobutyric acid (GABA) in cancer progression is an emerging area of research.
Purpose of the Study:
- To elucidate the function of GABA in HCC metastasis.
- To evaluate GABA as a potential therapeutic agent for HCC.
Main Methods:
- Quantitative real-time PCR and Western blot to assess GABA receptor subunit gene expression in HCC tissues and cell lines.
- Transwell assays to evaluate the impact of GABA on cancer cell migration and invasion.
- Immunofluorescence staining to analyze cytoskeletal changes in response to GABA.
- In vivo orthotopic mouse models to assess the effect of GABA on HCC metastasis.
Main Results:
- GABA receptor subunit gene expression varied between HCC and non-tumor tissues.
- GABA significantly inhibited HCC cell migration and invasion, mediated by the GABAA receptor and cytoskeletal reorganization.
- In vivo studies demonstrated that GABA pretreatment reduced intrahepatic metastasis and primary tumor formation.
Conclusions:
- GABA plays a critical role in regulating HCC metastasis.
- Targeting the GABAergic system presents a promising novel therapeutic avenue for HCC.
- Further research into GABAergic modulation could lead to new cancer treatments.
